期刊文献+

组蛋白甲基化酶SMYD3在前列腺癌组织的表达及对mTOR通路的影响 被引量:8

Expression of histone methyltransferase SMYD3 in prostate cancer tissues and its role in mTOR pathway
原文传递
导出
摘要 目的探讨组蛋白甲基化酶SMYD3在前列腺癌组织的表达水平及其对前列腺癌细胞生长的影响。方法免疫组化染色检测33例前列腺癌及癌旁组织的SMYD3表达水平;siRNA及SMYD3过表达质粒分别转染前列腺癌LNCa P和PC3细胞,检测其对前列腺癌细胞系生长的影响;Western blotting检测前列腺癌细胞中mTOR通路相关蛋白表达水平。结果 SMYD3在前列腺癌组织的表达水平明显高于癌旁组织,且SMYD3在胞核胞浆中均可检测到;转染SMYD3 siRNA后处理组LNCa P细胞在不同生长时期均少于对照组;而PC3细胞在转染SMYD3过表达质粒后细胞数则多于对照组。处理后,LNCa P细胞p-mTOR、p-p70S6K基因表达降低(P<0.05),而p-4EBP-1蛋白表达上升(P<0.05);PC3细胞呈现一致趋势。结论前列腺癌组织中SMYD3表达水平高于癌旁组织,且在胞核胞浆中均有表达;SMYD3表达可以促进前列腺癌细胞的生长;且可通过激活mTOR基因,参与mTOR通路的调节,影响前列腺癌细胞系的生长。 Objective To determine the expression of histone methyltransferase SMYD3 in prostate cancer tissues and to explore its role and mechanism in prostate cancer progression. Methods The expression of SMYD3 in 33 pairs of prostate cancer tissues and matched non-tumor tissues were detected with immunohistochemical staining. Prostate cancer cell line LNCa P and PC3 were transfected with siRNA and SMYD3 over-expressing vectors,respectively,to evaluate their growth. The expressions of proteins involved in mTOR pathway were evaluated with Western blotting. Results Prostate cancer had over-expressed SMYD3 compared with non-tumor normal tissues. The SMYD3 expression could be found in both nucleus and cytoplasm. SMYD3 abundance had a positive correlation with cell proliferation. The number of LNCa P cells was lower in SMYD3 siRNA group compared with the control group,and the number of PC3 cells was higher in SMYD3-PC vector group than in the control group. The depletion of the enzyme could down-regulate the expression of p-mTOR( P 0. 05) and p-p70S6K( P 0. 05),while the expression of p-4EBP-1( P 0. 05) could be up-regulated; the trend of protein expression in mTOR pathway in PC3 was similar to that in LNCa P. Conclusion SMYD3 is over-expressed in prostate cancer tissues compared with non-tumor tissues,and SMYD3 can be expressed both in nucleus and cytoplasm. The expression of SMYD3 can activate the growth of prostate cancer cells by activating mTOR pathway.
出处 《山东大学学报(医学版)》 CAS 北大核心 2016年第5期12-16,44,共6页 Journal of Shandong University:Health Sciences
基金 国家自然科学基金(81372765 81572515 81472395) 山东省自然科学基金(ZR2011HM055)
关键词 前列腺肿瘤 SMYD3 SIRNA mTOR通路 Prostate neoplasms SMYD3 SiRNA MTOR pathway
  • 相关文献

参考文献2

二级参考文献137

  • 1张青云,徐建军,王雅明.人神经元特异性烯醇化酶在肿瘤细胞系中的表达检测及意义[J].中华检验医学杂志,2005,28(7):728-731. 被引量:12
  • 2吴澄宇,那彦群,JorgeL.Yao,P.AnthonydiSant'Agnese,黄教悌.前列腺癌的神经内分泌分化[J].中华病理学杂志,2006,35(9):565-567. 被引量:7
  • 3Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90. 被引量:1
  • 4Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, et et. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 2012; 62: 220-4l. 被引量:1
  • 5Antonarakis ES, Feng Z, Trock BJ, Humphreys EB, Carducci MA, et a/. The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up. BJU Int 2012; 109: 32-9. 被引量:1
  • 6Caire AA, Sun l, Ode 0, Stackhouse DA, Maloney K, et al. Delayed prostate-specific antigen recurrence after radical prostatectomy: how to identify and what are their clinical outcomes? Urology 2009; 74: 643-7. 被引量:1
  • 7Eisenberger MA, Blumenstein BA, Crawfore ED, MillerG, Macleod DG, etal. Bilateral orchiectomy with or without flutamide for metastatic prostate cancer. N Engl J Med 1998; 339: 1036-42. 被引量:1
  • 8Tannock IF, de Wit R, BerryWR, Horti J, Pluzanska A, et al. Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for advanced prostate cancer. N Engl J Med 2004; 351: 1502-12. 被引量:1
  • 9Chen CD, Welsbie OS, Tran C, Baek SH, Chen R, et al. Molecular determinants of resistance to antiandrogen therapy. Nat Med 2004; 10: 33-9. 被引量:1
  • 10Wang Q, Li W, Zhang Y, Yuan X, Xu K, et al. Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. Cell 2009; 138: 245-56. 被引量:1

共引文献20

同被引文献53

引证文献8

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部